Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen

Journal of Immunological Methods

Volumn 378, Issue 1-2, 2012, Pages 81-87

  Chauvat, A ^a,b,c,d   Benhamouda, N ^a,b,c,d   Loison, E ^e   Gougeon, M L ^e   Gey, A ^a   Levionnois, E ^a   Ravel, P ^f   Abitbol, V ^g   Roncelin, S ^a   Marcheteau, E ^a,b   Quintin Colonna, F ^d   Fridman, W H ^a,c   Launay, O ^b,c,g   Tartour, E ^a,b,c,d  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^e INSTITUT PASTEUR   (France)

^f CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^g Groupe Hospitalier Cochin Broca Hôtel Dieu Service de gastro entérologie ^*  (France)

Author keywords

Elispot; Immunomonitoring; T cell response; Thimerosal; Vaccine

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE; T LYMPHOCYTE ANTIGEN; THIOMERSAL;

2009 H1N1 INFLUENZA; ANTIGEN DETECTION; ARTICLE; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNE RESPONSE; IN VIVO STUDY; INFLUENZA VACCINATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, VIRAL; CELL DEATH; CROSS PROTECTION; ENZYME-LINKED IMMUNOSPOT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PANDEMICS; T-LYMPHOCYTES; THIMEROSAL; VACCINATION;

EID: 84859425036     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.02.008     Document Type: Article

References (26)

1. Agrawal A., et al. Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells. J. Leukoc. Biol. 2007, 81:474-482.
2. Badoual C., et al. The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer. Cancer Res. 2008, 68:3907-3914.
3. Bercovici N., et al. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients. J. Immunother. 2008, 31:101-112.
4. Britten C.M., et al. The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol. Immunother. 2008, 57:289-302.
5. Darrah P.A., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 2007, 13:843-850.
6. Fournie G.J., et al. Th2-type immunopathological manifestations induced by mercury chloride or gold salts in the rat: signal transduction pathways, cellular mechanisms and genetic control. Autoimmun. Rev. 2002, 1:205-212.
7. Galli G., et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3877-3882.
8. Gazagne A., et al. A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines. J. Immunol. Methods 2003, 283:91-98.
9. Godard B., et al. Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes. Hum. Immunol. 2004, 65:1307-1318.
10. Guerkov R.E., et al. Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J. Immunol. Methods 2003, 279:111-121.
11. Haicheur N., et al. Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. Clin. Exp. Immunol. 2000, 119:28-37.
12. He X.S., et al. Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines. PLoS One 2008, 3:e2574.
13. Hesse M.D., et al. A T cell clone's avidity is a function of its activation state. J. Immunol. 2001, 167:1353-1361.
14. Hillaire M.L., et al. Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal A(H3N2) virus is mediated by virus-specific T cells. J Gen Virol. 2011, 92:2339-2392.
15. Makani S., et al. Biochemical and molecular basis of thimerosal-induced apoptosis in T cells: a major role of mitochondrial pathway. Genes Immun. 2002, 3:270-278.
16. McElhaney J.E., et al. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 2006, 176:6333-6339.
17. McKinstry K.K., et al. Hallmarks of CD4 T cell immunity against influenza. J. Intern. Med. 2011, 269:507-518.
18. Pere H., et al. A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. Blood 2011, 118:4853-4862.
19. Pittet M.J., et al. Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J. Immunol. 2001, 166:7634-7640.
20. Reardon C.L., Lucas D.O. Heavy-metal mitogenesis: Zn++ and Hg++ induce cellular cytotoxicity and interferon production in murine T lymphocytes. Immunobiology 1987, 175:455-469.
21. Scheible K., et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine 2011, 29:2159-2168.
22. Schlingmann T.R., et al. Increased per cell IFN-gamma productivity indicates recent in vivo activation of T cells. Cell. Immunol. 2009, 258:131-137.
23. Shenker B.J., et al. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. II. Alterations in cell viability. Immunopharmacol. Immunotoxicol. 1992, 14:555-577.
24. Thompson W.W., et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10years. N. Engl. J. Med. 2007, 357:1281-1292.
25. Vogt A., et al. Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J. Immunol. 2008, 180:1482-1489.
26. Winstone N., et al. Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay. Eur. J. Immunol. 2009, 39:975-985.